Suppr超能文献

大鼠体内从D-亮氨酸经α-酮异己酸到L-亮氨酸的顺序代谢动力学。

Kinetics of sequential metabolism from D-leucine to L-leucine via alpha-ketoisocaproic acid in rat.

作者信息

Hasegawa Hiroshi, Matsukawa Takehisa, Shinohara Yoshihiko, Hashimoto Takao

机构信息

Department of Pathophysiology, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan.

出版信息

Drug Metab Dispos. 2002 Dec;30(12):1436-40. doi: 10.1124/dmd.30.12.1436.

Abstract

D-Leucine is considered to be converted into the L-enantiomer by two steps: oxidative deamination to form alpha-ketoisocaproic acid (KIC) and subsequent stereospecific reamination of KIC. We investigated the pharmacokinetics of leucine enantiomers and KIC in rats to evaluate how deamination of D-leucine, reamination of KIC, and decarboxylation of KIC were affected to the overall extent that converted D-leucine into the L-enantiomer. After intravenous administrations of D-[(2)H(7)]leucine, L-[(2)H(7)]leucine, or [(2)H(7)]KIC, their plasma concentrations together with endogenous L-leucine and KIC were determined by gas chromatography-mass spectrometry. The rapid appearances of [(2)H(7)]KIC and L-[(2)H(7)]leucine were observed after administration of D-[(2)H(7)]leucine, whereas no detectable amount of D-[(2)H(7)]leucine was found after administrations of [(2)H(7)]KIC or L-[(2)H(7)]leucine. The fraction of conversion from D-[(2)H(7)]leucine into [(2)H(7)]KIC (F(D-->KIC)) was estimated by using the area under the curve (AUC) of [(2)H(7)]KIC on the D-[(2)H(7)]leucine administration [AUC(KIC(D))] and that of [(2)H(7)]KIC on the [(2)H(7)]KIC administration (AUC(KIC)) to yield 70.1%. The fraction of conversion from [(2)H(7)]KIC to L-[(2)H(7)]leucine (F(KIC-->L)) was 40.2%. The fraction of conversion from D-leucine to the L-enantiomer (F(D-->L)) was considered to be the product of F(D-->KIC) and F(KIC-->L), indicating that 28.2% of D-[(2)H(7)]leucine was metabolized to L-[(2)H(7)]leucine via [(2)H(7)]KIC. These results suggested that the relatively low conversion of D-leucine into the L-enantiomer might depend on irreversible decarboxylation of KIC. Regardless of [(2)H(7)]KIC, F(D-->L) was also calculated directly using AUC(L(D)) and AUC(L) to yield 27.5%. There were no differences between the two F(D-->L) values, suggesting that almost all of the formation of L-[(2)H(7)]leucine from D-[(2)H(7)]leucine occurred via [(2)H(7)]KIC as an intermediate.

摘要

D-亮氨酸被认为通过两步转化为L-对映体:氧化脱氨形成α-酮异己酸(KIC),随后KIC进行立体特异性再氨基化。我们研究了大鼠体内亮氨酸对映体和KIC的药代动力学,以评估D-亮氨酸的脱氨、KIC的再氨基化以及KIC的脱羧对将D-亮氨酸转化为L-对映体的总体程度的影响。静脉注射D-[(2)H(7)]亮氨酸、L-[(2)H(7)]亮氨酸或[(2)H(7)]KIC后,通过气相色谱-质谱法测定它们的血浆浓度以及内源性L-亮氨酸和KIC的浓度。静脉注射D-[(2)H(7)]亮氨酸后,观察到[(2)H(7)]KIC和L-[(2)H(7)]亮氨酸迅速出现,而静脉注射[(2)H(7)]KIC或L-[(2)H(7)]亮氨酸后未发现可检测到的D-[(2)H(7)]亮氨酸。通过使用静脉注射D-[(2)H(7)]亮氨酸时[(2)H(7)]KIC的曲线下面积(AUC)[AUC(KIC(D))]和静脉注射[(2)H(7)]KIC时[(2)H(7)]KIC的曲线下面积(AUC(KIC))来估计从D-[(2)H(7)]亮氨酸转化为[(2)H(7)]KIC的转化率(F(D→KIC)),结果为70.1%。从[(2)H(7)]KIC转化为L-[(2)H(�)]亮氨酸的转化率(F(KIC→L))为40.2%。从D-亮氨酸转化为L-对映体的转化率(F(D→L))被认为是F(D→KIC)和F(KIC→L)的乘积,这表明28.2%的D-[(2)H(7)]亮氨酸通过[(2)H(7)]KIC代谢为L-[(2)H(7)]亮氨酸。这些结果表明,D-亮氨酸向L-对映体的相对低转化率可能取决于KIC的不可逆脱羧。无论是否存在[(2)H(7)]KIC,也直接使用AUC(L(D))和AUC(L)计算F(D→L),结果为27.5%。两个F(D→L)值之间没有差异表明,从D-[(2)H(7)]亮氨酸形成L-[(2)H(7)]亮氨酸几乎全部通过[(2)H(7)]KIC作为中间体发生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验